EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 57 filers reported holding EDGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $52,000 | -90.1% | 63,780 | -87.5% | 0.00% | -100.0% |
| Q2 2018 | $526,000 | +2290.9% | 510,212 | +2686.1% | 0.00% | – |
| Q1 2018 | $22,000 | -99.2% | 18,313 | -93.4% | 0.00% | -100.0% |
| Q4 2017 | $2,609,000 | -24.3% | 278,391 | -13.3% | 0.00% | -20.0% |
| Q3 2017 | $3,446,000 | +5.1% | 321,116 | +0.5% | 0.01% | -16.7% |
| Q2 2017 | $3,279,000 | +1.5% | 319,564 | -9.9% | 0.01% | 0.0% |
| Q1 2017 | $3,230,000 | -7.2% | 354,578 | +27.4% | 0.01% | -14.3% |
| Q4 2016 | $3,480,000 | +19.0% | 278,407 | -0.9% | 0.01% | +40.0% |
| Q3 2016 | $2,924,000 | +16.1% | 280,879 | +12.8% | 0.01% | -16.7% |
| Q2 2016 | $2,518,000 | +38.0% | 249,048 | +24.9% | 0.01% | +20.0% |
| Q1 2016 | $1,825,000 | -19.7% | 199,467 | +9.7% | 0.01% | 0.0% |
| Q4 2015 | $2,273,000 | – | 181,818 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |